水溶性差的药物水飞蓟素的增溶性和抗氧化潜力

IF 0.3 Q4 PHARMACOLOGY & PHARMACY
Ashwani K. Dhingra, Deepshi Arora, Yugam Taneja, Kumar Guarve, Muskan Chauhan, Kajal Nagpal
{"title":"水溶性差的药物水飞蓟素的增溶性和抗氧化潜力","authors":"Ashwani K. Dhingra, Deepshi Arora, Yugam Taneja, Kumar Guarve, Muskan Chauhan, Kajal Nagpal","doi":"10.2174/1574885518666230418114203","DOIUrl":null,"url":null,"abstract":"\n\nSilymarin is extracted from the seeds of milk thistle (Silybum marianum), exhibits antioxidant properties, and is considered to treat numerous hepatic ailments like chronic liver\ndisease, cirrhosis, and chemical degradation of liver cells and prevent hepatotoxicity from various\ndrugs.\n\n\n\nThe objective of the present study was to preclude the problem of poor dissolution of the\nrelatively water-insoluble drug by formulating solid dispersions of the drug.\n\n\n\nSolid dispersions of silymarin were prepared by solvent evaporation method by using different polymers, i.e., PEG 6000 and poloxamer 407, in various ratios such as 1:2, 1:4 and 1:6. The\ncompatibility of ingredients with the drug was tested by using Differential scanning calorimetry\n(DSC), X-Ray Diffractometry, and Fourier Transform-Infrared Spectroscopy (FT-IR). The scavenging\nactivity of DPPH (2,2 diphenyl-1-picrylhydrazyl) radical was used to study the antioxidant activity,\nand an in vitro release study was conducted using phosphate buffer pH 6.8 as dissolution medium followed by the kinetic assessment to study the drug release mechanism.\n\n\n\nSolid dispersions with different polymers were successfully prepared by the solvent evaporation method. FTIR spectroscopy and DSC showed no chemical interaction between the drug and\npolymers. Powder XRD analyses of optimized solid dispersions showed a relative decrease in\ncrystallinity compared to the pure drug. The dissolution profile of solid dispersions successfully\nexhibited 90.78% drug released, and the optimized batch was found to follow Higuchi drug release\nkinetics with an R2 value of 0.990. Furthermore, the optimized formulation F6 showed higher\nantioxidant activity compared to pure silymarin and ascorbic acid.\n\n\n\nThe elevated bioavailability, as well as absorption, consistently regulates the specific\ntherapeutic effect of the water-insoluble drug. The specific response of silymarin to various bodily\nfunctions upgrades various activities like anti-aging effects, anti-cancer, antihypertensive, etc. Solid\ndispersion of drugs with good aqueous solubility results in a decrease in dose frequency and enhanced\nspecificity of the drug mechanism.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Solubility Enhancement and Antioxidant Potential of Silymarin: A Poorly Water-Soluble Drug\",\"authors\":\"Ashwani K. Dhingra, Deepshi Arora, Yugam Taneja, Kumar Guarve, Muskan Chauhan, Kajal Nagpal\",\"doi\":\"10.2174/1574885518666230418114203\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nSilymarin is extracted from the seeds of milk thistle (Silybum marianum), exhibits antioxidant properties, and is considered to treat numerous hepatic ailments like chronic liver\\ndisease, cirrhosis, and chemical degradation of liver cells and prevent hepatotoxicity from various\\ndrugs.\\n\\n\\n\\nThe objective of the present study was to preclude the problem of poor dissolution of the\\nrelatively water-insoluble drug by formulating solid dispersions of the drug.\\n\\n\\n\\nSolid dispersions of silymarin were prepared by solvent evaporation method by using different polymers, i.e., PEG 6000 and poloxamer 407, in various ratios such as 1:2, 1:4 and 1:6. The\\ncompatibility of ingredients with the drug was tested by using Differential scanning calorimetry\\n(DSC), X-Ray Diffractometry, and Fourier Transform-Infrared Spectroscopy (FT-IR). The scavenging\\nactivity of DPPH (2,2 diphenyl-1-picrylhydrazyl) radical was used to study the antioxidant activity,\\nand an in vitro release study was conducted using phosphate buffer pH 6.8 as dissolution medium followed by the kinetic assessment to study the drug release mechanism.\\n\\n\\n\\nSolid dispersions with different polymers were successfully prepared by the solvent evaporation method. FTIR spectroscopy and DSC showed no chemical interaction between the drug and\\npolymers. Powder XRD analyses of optimized solid dispersions showed a relative decrease in\\ncrystallinity compared to the pure drug. The dissolution profile of solid dispersions successfully\\nexhibited 90.78% drug released, and the optimized batch was found to follow Higuchi drug release\\nkinetics with an R2 value of 0.990. Furthermore, the optimized formulation F6 showed higher\\nantioxidant activity compared to pure silymarin and ascorbic acid.\\n\\n\\n\\nThe elevated bioavailability, as well as absorption, consistently regulates the specific\\ntherapeutic effect of the water-insoluble drug. The specific response of silymarin to various bodily\\nfunctions upgrades various activities like anti-aging effects, anti-cancer, antihypertensive, etc. Solid\\ndispersion of drugs with good aqueous solubility results in a decrease in dose frequency and enhanced\\nspecificity of the drug mechanism.\\n\",\"PeriodicalId\":11004,\"journal\":{\"name\":\"Current Drug Therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2023-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Drug Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1574885518666230418114203\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574885518666230418114203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

水飞蓟是从水飞蓟(Silybum marianum)的种子中提取的,具有抗氧化特性,被认为可以治疗许多肝脏疾病,如慢性肝病、肝硬化和肝细胞化学降解,并预防各种药物的肝毒性。本研究的目的是通过配制药物的固体分散体来解决相对不溶于水的药物溶解不良的问题。通过溶剂蒸发法,使用不同的聚合物,即PEG 6000和泊洛沙姆407,以1:2、1:4和1:6的不同比例制备水飞蓟素的固体分散体。通过差示扫描量热法(DSC)、X射线衍射法和傅立叶变换红外光谱法(FT-IR)测试了这些成分与药物的相容性。采用DPPH(2,2-二苯基-1-二芳基肼基)自由基的清除活性来研究其抗氧化活性,并以pH 6.8的磷酸盐缓冲液为溶出介质进行体外释放研究,然后进行动力学评价来研究药物释放机制。采用溶剂蒸发法制备了不同聚合物的固体分散体。FTIR光谱和DSC显示药物和聚合物之间没有化学相互作用。优化的固体分散体的粉末XRD分析显示,与纯药物相比,结晶度相对降低。固体分散体的溶出度曲线成功地显示出90.78%的药物释放,并且发现优化的批次符合Higuchi药物释放动力学,R2值为0.990。此外,与纯水飞蓟素和抗坏血酸相比,优化配方F6显示出更高的抗氧化活性。提高的生物利用度和吸收,一致调节水不溶性药物的特定治疗效果。水飞蓟素对各种身体功能的特异性反应提升了抗衰老、抗癌、抗高血压等多种活性。水溶性好的药物的固体分散导致剂量频率降低,增强了药物机制的特异性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Solubility Enhancement and Antioxidant Potential of Silymarin: A Poorly Water-Soluble Drug
Silymarin is extracted from the seeds of milk thistle (Silybum marianum), exhibits antioxidant properties, and is considered to treat numerous hepatic ailments like chronic liver disease, cirrhosis, and chemical degradation of liver cells and prevent hepatotoxicity from various drugs. The objective of the present study was to preclude the problem of poor dissolution of the relatively water-insoluble drug by formulating solid dispersions of the drug. Solid dispersions of silymarin were prepared by solvent evaporation method by using different polymers, i.e., PEG 6000 and poloxamer 407, in various ratios such as 1:2, 1:4 and 1:6. The compatibility of ingredients with the drug was tested by using Differential scanning calorimetry (DSC), X-Ray Diffractometry, and Fourier Transform-Infrared Spectroscopy (FT-IR). The scavenging activity of DPPH (2,2 diphenyl-1-picrylhydrazyl) radical was used to study the antioxidant activity, and an in vitro release study was conducted using phosphate buffer pH 6.8 as dissolution medium followed by the kinetic assessment to study the drug release mechanism. Solid dispersions with different polymers were successfully prepared by the solvent evaporation method. FTIR spectroscopy and DSC showed no chemical interaction between the drug and polymers. Powder XRD analyses of optimized solid dispersions showed a relative decrease in crystallinity compared to the pure drug. The dissolution profile of solid dispersions successfully exhibited 90.78% drug released, and the optimized batch was found to follow Higuchi drug release kinetics with an R2 value of 0.990. Furthermore, the optimized formulation F6 showed higher antioxidant activity compared to pure silymarin and ascorbic acid. The elevated bioavailability, as well as absorption, consistently regulates the specific therapeutic effect of the water-insoluble drug. The specific response of silymarin to various bodily functions upgrades various activities like anti-aging effects, anti-cancer, antihypertensive, etc. Solid dispersion of drugs with good aqueous solubility results in a decrease in dose frequency and enhanced specificity of the drug mechanism.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信